உலகளாவிய முயற்சி க்கு ஆஸ்துமா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Thursday, 15 July 2021, 2:42 pm The Medical Research Institute of New Zealand (MRINZ) has dedicated much of its research focus over the last two decades to the prevention and management of asthma, both here at home in Aotearoa, New Zealand and around the world. MRINZ’s asthma research has included three landmark studies which have shown that a 2 in1 inhaler, containing both a preventer and reliever medication, is far more effective than the traditional single reliever inhaler, which has been the basis of asthma management for over 60 years. These MRINZ studies have shown that the as-needed use of the combined 2 in 1 inhaler, referred to as

New zealand generalNew zealandSymbicort turbuhalerGraeme hansenRichard beasleyPepa bruceResearch institute of new zealand on infopagesResearch organisationCitizen communityAsthma researchFoundation for public interest journalismResearch instituteResearch institute of new zealandClinical researchGlobal initiative for asthmaHealth research council of new zealand